
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sarcospan CRISPR/Cas9 KO Plasmid (m) | sc-421332 | 20 µg | $397.00 |
Sspn encodes sarcospan, a tetraspan membrane protein that forms part of the dystrophin–glycoprotein complex and helps organize the sarcolemma by stabilizing laminin-binding receptor assemblies. In skeletal and cardiac muscle, sarcospan supports membrane integrity during contraction and contributes to mechanotransduction by influencing the distribution and function of associated sarcoglycans and integrins. Altered sarcospan-dependent complex assembly has been linked to muscle fragility and impaired regeneration, making Sspn a useful entry point for studying pathways relevant to muscular dystrophy phenotypes. Because sarcospan also impacts extracellular matrix interactions and membrane microdomain organization, it is frequently examined in models of myofiber damage, inflammation, and remodeling.
Sarcospan CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sspn gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sspn together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sspn open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sarcospan protein expression.
This CRISPR knockout system enables efficient generation of Sspn-deficient cell models for investigation of Sarcospan signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.